SHANGHAI, July 19 (Reuters) - Eli Lilly (LLY.N), opens new tab said in a social media post, opens new tab Friday its weight loss drug tirzepatide had received approval from Chinese regulators, further intensifying competition with its Danish rival Novo Nordisk (NOVOb.CO), opens new tab in the key Asian market.
Eli Lilly has partnered with seven-times Olympic medalist Simone Biles and her mom Nellie to promote the GLP-1 diabetes drug Mounjaro.
India panel urges drug regulator to approve Lilly`s obesity drug Mounjaro
Terns Pharmaceuticals’ prediction that its shelved metabolic dysfunction-associated steatohepatitis (MASH) drug TERN-501 could be effective against obesity in a combination treatment appears to be playing out, at least preclinically.
SHANGHAI, June 25 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Tuesday its popular weight-loss drug Wegovy has been approved in China, paving the way for sales in the world's second-largest economy. nNovo said in March that it would initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug.
GLP-1 drugs like Eli Lilly's Zepbound and Novo Nordisk's Wegovy work to address obesity—as long as a patient keeps taking them.
COPENHAGEN, June 24 (Reuters) - Doctors in Denmark should limit how many packs of Novo Nordisk's (NOVOb.CO), opens new tab Ozempic diabetes drug patients can pick up at one time, the Danish Patient Safety Authority said on Monday, amid worries that some may acquire a larger supply than needed.
Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients
WHO issues warnings on fake copies of Novo Nordisk`s weight-loss drugs
That's because the latest formulations, Novo Nordisk A/S's Ozempic and Wegovy and Eli Lilly & Co's Mounjaro and Zepbound, won't be available in India anytime soon, amid global supply shortages. For some buyers, that's not soon enough